1. Home
  2. BATL vs LCTX Comparison

BATL vs LCTX Comparison

Compare BATL & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BATL
  • LCTX
  • Stock Information
  • Founded
  • BATL 1987
  • LCTX 1990
  • Country
  • BATL United States
  • LCTX United States
  • Employees
  • BATL N/A
  • LCTX N/A
  • Industry
  • BATL Oil & Gas Production
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BATL Energy
  • LCTX Health Care
  • Exchange
  • BATL Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • BATL 109.4M
  • LCTX 110.2M
  • IPO Year
  • BATL N/A
  • LCTX N/A
  • Fundamental
  • Price
  • BATL $2.76
  • LCTX $0.56
  • Analyst Decision
  • BATL
  • LCTX Strong Buy
  • Analyst Count
  • BATL 0
  • LCTX 4
  • Target Price
  • BATL N/A
  • LCTX $5.25
  • AVG Volume (30 Days)
  • BATL 67.9K
  • LCTX 4.2M
  • Earning Date
  • BATL 11-12-2024
  • LCTX 11-14-2024
  • Dividend Yield
  • BATL N/A
  • LCTX N/A
  • EPS Growth
  • BATL N/A
  • LCTX N/A
  • EPS
  • BATL N/A
  • LCTX N/A
  • Revenue
  • BATL $191,482,000.00
  • LCTX $8,719,000.00
  • Revenue This Year
  • BATL $2.21
  • LCTX N/A
  • Revenue Next Year
  • BATL N/A
  • LCTX $123.52
  • P/E Ratio
  • BATL N/A
  • LCTX N/A
  • Revenue Growth
  • BATL N/A
  • LCTX N/A
  • 52 Week Low
  • BATL $2.48
  • LCTX $0.48
  • 52 Week High
  • BATL $9.69
  • LCTX $1.61
  • Technical
  • Relative Strength Index (RSI)
  • BATL 19.98
  • LCTX 38.21
  • Support Level
  • BATL $2.75
  • LCTX $0.48
  • Resistance Level
  • BATL $3.45
  • LCTX $0.61
  • Average True Range (ATR)
  • BATL 0.15
  • LCTX 0.05
  • MACD
  • BATL 0.04
  • LCTX 0.00
  • Stochastic Oscillator
  • BATL 6.03
  • LCTX 38.93

About BATL Battalion Oil Corporation

Battalion Oil Corp is an independent oil and gas producer operating exclusively in the Delaware Basin. It is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the United States. The company operates in one segment which focuses on oil and natural gas acquisition, production, exploration, and development.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: